GW
GSK icon

GW & Wade’s GSK GSK Stock Holding History

GW & Wade’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,583
Closed -$427K – 387
2021
Q2 		$427K Sell
8,583
-467
-5% -$22.4K 0.02% 266
2021
Q1 		$404K Sell
9,050
-7,840
-46% -$356K 0.02% 249
2020
Q4 		$777K Buy
16,890
+1,521
+10% +$69.9K 0.05% 159
2020
Q3 		$723K Sell
15,369
-237
-2% -$11.9K 0.06% 131
2020
Q2 		$796K Buy
15,606
+432
+3% +$22.2K 0.07% 128
2020
Q1 		$719K Sell
15,174
-1,660
-10% -$88.5K 0.07% 122
2019
Q4 		$989K Buy
16,834
+1,320
+9% +$73.4K 0.08% 122
2019
Q3 		$828K Buy
15,514
+192
+1% +$9.88K 0.07% 122
2019
Q2 		$767K Buy
+15,322
New +$769K 0.07% 124
2019
Q1 		– Sell
-10,554
Closed -$504K – 234
2018
Q4 		$504K Sell
10,554
-5,736
-35% -$282K 0.05% 139
2018
Q3 		$818K Hold
16,290
– – 0.09% 121
2018
Q2 		$821K Hold
16,290
– – 0.09% 118
2018
Q1 		$796K Hold
16,290
– – 0.09% 119
2017
Q4 		$722K Sell
16,290
-80
-0.5% -$3.7K 0.08% 120
2017
Q3 		$831K Buy
16,370
+152
+0.9% +$7.71K 0.1% 107
2017
Q2 		$874K Sell
16,218
-40
-0.2% -$2.13K 0.11% 104
2017
Q1 		$857K Hold
16,258
– – 0.11% 101
2016
Q4 		$783K Sell
16,258
-214
-1% -$10.6K 0.13% 98
2016
Q3 		$888K Buy
+16,472
New +$903K 0.16% 93

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GW & Wade's GSK Position: Q3 2021 in Review

GW & Wade sold out of GSK (GSK) in Q3 2021, closing a stake of 8,583 shares — an estimated $427K sold.

GW & Wade first reported a position in GSK in Q3 2016 and held it in 19 quarters. The position peaked at $989K in Q4 2019. 792 funds tracked by Wall St. Rank hold GSK as of Q3 2021.

  • GW & Wade reported no remaining GSK position as of Q3 2021 after selling out during the quarter.
  • GW & Wade sold 8,583 GSK shares in Q3 2021, an estimated $427K.
  • GW & Wade first reported a position in GSK in Q3 2016 and held it in 19 quarters.
  • GW & Wade's GSK position peaked at $989K in Q4 2019.
  • 792 funds tracked by Wall St. Rank held GSK as of Q3 2021.

Based on GW & Wade's 13F filing for Q3 2021, filed 3 Nov 2021.